Direct Marketing

Remedy offers docs (and advertisers) a platform for direct communication with patients

By

Remedy Health is looking to close the loop—and sell advertising off of it—with the launch of a service letting doctors, pharmacies and other healthcare providers send topical health content to their patients.

Print: Still not dead

By

Studies show that printed pieces still hold sway in the industry.

Pfizer's post-expiry plan for Lipitor: maximize brand's sales

By

Pfizer said it plans not only to keep Lipitor consumer promotions running past the brand's expiry later this month. It also aims to put an OTC version of the megablockbuster on the market at some point.

Merck web widget points to future adherence fix

Merck web widget points to future adherence fix

By

Asking consumers to gauge their risk for non-adherence, Merck is deploying a one-minute survey dubbed the Adherence Estimator that may be the way forward for keeping patients on-treatment.

DDMAC pokes Allergan on eye drop direct mail

DDMAC pokes Allergan on eye drop direct mail

By

Allergan has a superiority complex when it comes to marketing its ophthalmic drops, as evidenced by a second DDMAC Untitled Letter posted online yesterday.

Federal appeals court overturns Vermont data ban

By

A federal appeals court on Tuesday reversed a district court ruling that limited the use of prescriber-identifiable data in Vermont, signaling a victory for plaintiffs IMS Health, SDI and Wolters Kluwer Health.

New database lets marketers make house calls to docs

By

Healthcare Data Solutions (HDS) launched a new database providing home addresses and personal email account listings for physicians, dentists, nurses and other healthcare providers.

Pfizer nearly doubles amount spent on e-detailing

By

Pfizer increased its spending on online professional promotion by more than 90% last year, according to a study, a sign the drugmaker is emphasizing alternatives to live sales reps for detailing certain products.

Only a tenth of scripts are up for grabs, says IMS study

By

Traditional promotion efforts, including details and sampling, can only affect about 10% of prescriptions, an IMS study found, suggesting that the bulk of promotion dollars is misplaced.

Sanofi, Cegedim launch mobile CRM for managed markets

By

Sanofi-Aventis partnered with Cegedim Dendrite to launch a CRM mobile platform for its managed market managers. The three-year agreement spans 28 countries, including the US, France and Japan.

Last chance to grab glory

Last chance to grab glory

If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions.

Abbott, AZ extend co-promotion to Trilipix

Abbott, AZ extend co-promotion to Trilipix

By

AstraZeneca will help Abbott reach more physicians with its Trilipix (fenofibric acid) drug, a cholesterol product approved by FDA last December. The companies also filed an NDA for Certriad, a Trilipix/Crestor combination drug.

Non-compliance, requests for generics on the rise, says survey

By

Physicians say patient compliance is getting worse, and they're hearing more requests for generic or OTC alternatives to prescribed medications as the economic malaise takes its toll, according to a PriMed survey.

DTC spend set to slide, loyalty cards up, says survey

By

Marketers anticipate substantial cuts in DTC spend in 2009, according to a Cegedim Dendrite survey in which 58% of respondents said they'd cut consumer ad spend this year. Last year 28% said they'd cut back on consumer advertising.

Vermont upholds commercial data ban

Vermont upholds commercial data ban

By

A federal court in Vermont quashed the efforts of several marketing research firms to overturn a statewide ban that restricts the use of prescriber-identifiable data.

GSK to co-promote Shire's Vyvanse

GSK to co-promote Shire's Vyvanse

By

GlaxoSmithKline will partner with Shire to co-promote Vyvanse, Shire's Adderall follow-on ADHD drug. The three-year deal will double the brand's sales force, with 600 GSK reps targeting primary care physicians and specialists, the companies announced today.

GSK pairs Wynonna Judd album with Alli

By

Consumers purchasing GSK's weight loss drug Alli will receive a free copy of Wynonna Judd's new album "Sing," beginning in March.

MedPAC calls for reporting of samples

By

An influential advisory board urged Congress to impose far-reaching transparency rules on payments to healthcare professionals and organizations interacting with the drug industry--including reporting samples, in part to aid counterdetailing efforts.

DOJ: Forest promoted Celexa and Lexapro off-label

DOJ: Forest promoted Celexa and Lexapro off-label

By

The Department of Justice is suing Forest Laboratories over the alleged promotion of Celexa and Lexapro off-label, for pediatric use. Forest also paid kickbacks to physicians, the DOJ said.

Generics taking a greater toll on pharma sales forces

By

The number of working sales reps in the US dropped below 93,000 in 2008, from an all-time high of 102,000 in 2005, according to an SDI report. Numbers are expected to decline further in 2009.

Report: Pfizer set to cut sales force by up to 2,400 reps

By

Pfizer could reduce its sales force by one-third, or 2,400 reps, according to a Bloomberg report that cited anonymous sources.

ImClone to trim sales forces from 70 reps to 40

By

ImClone, recently acquired by Lilly for $6.5 billion, will cut 30 of its 70 in-house sales reps.

Sanofi-Aventis to cut hundreds of US sales reps

By

Sanofi-Aventis announced plans to cut 10% or less of its 6,500 US sales reps. Specific numbers are not yet available, as the company attempts to shuffle some of the redundant positions to other areas of the company, according to Marc Greene, a Sanofi spokesman.

Court rules against IMS, SDI on NH data ban

Court rules against IMS, SDI on NH data ban

By

A federal appeals court has overturned a lower court's injunction of New Hampshire's ban on commercial provision of prescription data, arguing that such restrictions do not constitute an abridgment of free speech.

Wanted: smarter reps, says survey

By

A snap survey of physicians found a yearning for smarter sales reps who know their disease states back and forth and can use clinical studies in their details.

Customized journal offers à la carte content

Customized journal offers à la carte content

By

Sequence Medical is launching what it claims to be the first-ever individually customizable medical journal in the US.

HAVAS partners with WebMD on "Virtual Convention Booth"

HAVAS partners with WebMD on "Virtual Convention Booth"

By

Euro RSCG Life parent HAVAS is partnering with WebMD for a new Virtual Convention Booth offering that aims to give healthcare professionals the 3D interactive experience online.

'Fully Engaged' docs more open to influence

By

A new study measuring physician engagement levels with reps found that prescribing behavior is influenced significantly by social chemistry.

PDI seeks new CEO following Marquad retirement

By

Contract sales firm PDI has announced the retirement of its CEO Michael Marquard.

Docs rate Merck tops for ePromotion

By

Doctors rate Merck's ePromotion efforts as tops in the industry, according to pharmaceutical marketing data firm Verispan.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters